Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective

Clin Transl Sci. 2018 Jan;11(1):11-20. doi: 10.1111/cts.12501. Epub 2017 Oct 23.

¹ Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia, Perth, Australia.
² Directorate General for Research and Innovation (DG RTD), European Commission, Brussels, Belgium, (until April 2017).
³ Merck & Co. Inc., Upper Gwynedd, Pennsylvania, USA, (from June 2017).
⁴ Department of Biology, McGill University, Montréal, Canada.
⁵ IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France.
⁶ National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA.
⁷ Orphanet, Inserm-US14, Rare Diseases Platform, Paris, France.
⁸ Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
⁹ Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.
¹⁰ Western Australian Register of Developmental Anomalies, Perth, Australia.
¹¹ Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
¹² EURORDIS-Rare Diseases Europe, Paris, France.

No abstract available

Publication types